Latham & Watkins and Baker McKenzie advised ZF Friedrichshafen AG (ZF) on the deal. Noerr advised AEQUITA. ZF Friedrichshafen AG (ZF) announced the carve-out and sale...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented London Stock Exchange Group in the transaction while Sidley advised Clearlake Capital Group, L.P. and Motive Partners. London Stock Exchange Group plc...
You must be a Standard 1 Year member to access this content.
IN BRIEF: Latham & Watkins, advised on the matter. Latham & Watkins advised DAMS Développement with a team including Pierre-Louis Cl?o (Picture – Corporate M&A). Read...
You must be a Standard 1 Year member to access this content.
IN BRIEF: Latham & Watkins, Noerr, advised on the matter. Latham & Watkins advised ZF Friedrichshafen AG with a team including Heiko Gotsche (Corporate M&A), Sibylle...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Ara Partners in the transaction. Ara Partners, a private equity firm that specialises in industrial decarbonisation investments, has announced its partnership to...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented ParaFi Capital in the transaction. OXIO, the first telecom-as-a-service platform for brands and enterprises with a white-label, fully-customizable solution to help turn...
You must be a Standard 1 Year member to access this content.
Latham & Watkins has advised Octopus Ventures as lead investor on the round. Vira Health, a digital health company focused on improving the long-term health of...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer and Skadden advised Anaplan on the deal. Kirkland and Ellis and Cadwalader, Wickersham & Taft advised Thoma Bravo. Latham & Watkins represented the direct...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented SLR Investment Corp. in the transaction. Vapotherm, Inc., a global medical technology company focused on the development and commercialization of non-invasive technologies...
You must be a Standard 1 Year member to access this content.
Latham & Watkins, Torys LLP and Goodwin represented Triumvira Immunologics in the transaction. Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell...
You must be a Standard 1 Year member to access this content.
Latham & Watkins and Ketler & Partners represented Textron in the transaction, Fabiani, Petrovic, Jeraj, Rejc Attorneys-at-Law advised Pipistrel Group. Textron Inc. (NYSE: TXT), home to...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Clarify Health in the transaction. Clarify Health, a leading cloud analytics and value-based payments platform company, has announced the acquisition of Embedded...
You must be a Standard 1 Year member to access this content.
